What would a vaccine have to contain to protect a patient from chicken pox? Explain why we don't have vaccines for HIV.
What are two main criteria required for an RNA vaccine to be effective at protecting a vaccinated individual from a viral infection?
Verified Solution
Key Concepts
RNA Vaccine Mechanism
Immune Response Activation
Stability and Delivery of RNA
Which of the following outcomes would be expected if somatic hypermutation did not occur? a. The diversity of pattern-recognition receptors would be significantly lowered. b. B and T lymphocytes would not be able to produce receptors that recognize antigens. c. The adaptive immune response would not be activated by pathogens. d. The secondary immune response to a repeat infection would produce the same antibodies as those made in the primary immune response.
Propose a hypothesis to explain how self-reactive B cells are identified and eliminated during maturation.
Self-amplifying RNA vaccines currently being developed are typically derived from alphaviruses—Class IV, positive-sense, single-stranded RNA viruses. Explain why an alphavirus is a good choice.
Dr. Anna Blakney, bioengineer and RNA scientist, as part of a multidisciplinary team, compared the immune response from different formulations for delivering self-amplifying RNA encoding a viral antigen to cells. The team tested a cationic polymer (pABOL) and three lipid nanoparticles (LNPs). Five female mice per treatment group were intramuscularly immunized with increasing microgram (µg) doses of self-amplifying RNA formulated with PBS (phosphate-buffered saline control), pABOL, LNP1, LNP2, or LNP3. Blood was collected to measure the antibody responses at four (A) and six weeks (B). The colored dots represent individual animals, and the asterisks indicate 𝑃 values (for help interpreting the graph, see BioSkills 2 and 3). What conclusion is supported by the results shown in the dot plot graphs below?
Before the RNA is translated into a viral antigen that can induce an antibody response, what other cellular response could be triggered by a self-amplifying RNA vaccine?